- Home
- LMFA vs ATHA Comparison
LMFA vs ATHA Comparison
Compare LMFA & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMFA
- ATHA
- Stock Information
- Founded
- LMFA 2008
- ATHA 2011
- Country
- LMFA United States
- ATHA United States
- Employees
- LMFA N/A
- ATHA N/A
- Industry
- LMFA Finance: Consumer Services
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- LMFA Finance
- ATHA Health Care
- Exchange
- LMFA Nasdaq
- ATHA Nasdaq
- Market Cap
- LMFA 15.5M
- ATHA 16.1M
- IPO Year
- LMFA 2015
- ATHA 2020
- Fundamental
- Price
- LMFA $0.83
- ATHA $4.83
- Analyst Decision
- LMFA Strong Buy
- ATHA
- Analyst Count
- LMFA 1
- ATHA 0
- Target Price
- LMFA $5.00
- ATHA N/A
- AVG Volume (30 Days)
- LMFA 2.2M
- ATHA 21.9K
- Earning Date
- LMFA 11-14-2025
- ATHA 11-06-2025
- Dividend Yield
- LMFA N/A
- ATHA N/A
- EPS Growth
- LMFA N/A
- ATHA N/A
- EPS
- LMFA N/A
- ATHA N/A
- Revenue
- LMFA $7,567,508.00
- ATHA N/A
- Revenue This Year
- LMFA N/A
- ATHA N/A
- Revenue Next Year
- LMFA $15.59
- ATHA N/A
- P/E Ratio
- LMFA N/A
- ATHA N/A
- Revenue Growth
- LMFA N/A
- ATHA N/A
- 52 Week Low
- LMFA $0.78
- ATHA $2.20
- 52 Week High
- LMFA $5.14
- ATHA $7.00
- Technical
- Relative Strength Index (RSI)
- LMFA 38.61
- ATHA 68.41
- Support Level
- LMFA $0.78
- ATHA $4.42
- Resistance Level
- LMFA $1.14
- ATHA $5.00
- Average True Range (ATR)
- LMFA 0.13
- ATHA 0.33
- MACD
- LMFA -0.02
- ATHA 0.00
- Stochastic Oscillator
- LMFA 11.22
- ATHA 85.27
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.